At the presentation contest “Innovation Prize” sponsored by Beringer Ingelheim Japan Co., Ltd., our President & CEO, Hideaki  Sato, gave a presentation about “Antisense Oligonucleotide Therapy for Spinal Cord Injury”, which  was selected as the second place.

Click here for details on the contest(Japanese only).